Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gulf Coast Biologics is a premier regenerative medicine company and educational institution based in Fort Myers, Florida. The company specializes in providing healthcare professionals with comprehensive, hands-on training in the science and clinical application of autologous biologics, including Platelet-Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC). Operating a state-of-the-art training center, Gulf Coast Biologics focuses on standardizing regenerative protocols through evidence-based research and advanced laboratory techniques. In addition to its educational programs, the company offers specialized biologics processing equipment and kits designed to optimize cellular yields for orthopedic, aesthetic, and pain management treatments. By bridging the gap between laboratory science and clinical practice, Gulf Coast Biologics serves as a critical resource for practitioners seeking to integrate regenerative therapies into their medical practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gulf Coast Biologics.